Home

Boston Scientific (BSX)

103.85
+3.95 (3.95%)
NYSE · Last Trade: Oct 23rd, 3:29 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Top S&P500 movers in Wednesday's sessionchartmill.com
Curious about the S&P500 stocks that are in motion on Wednesday? Join us as we explore the top movers within the S&P500 index during today's session.
Via Chartmill · October 22, 2025
Tech Stocks Drop, Netflix Sinks 10% On Worst Day Since 2022: What's Moving Markets Wednesday?benzinga.com
Risk sentiment deteriorated sharply on Wednesday as a wave of disappointing earnings guidance and escalating U.S.-China trade tensions rattled investor confidence.
Via Benzinga · October 22, 2025
Boston Scientific To Acquire Privately-Held Pain Solutions Developer Nalu Medical For About $533Mstocktwits.com
Via Stocktwits · October 17, 2025
Boston Scientific (BSX) Stock Is Up, What You Need To Know
Shares of medical device company Boston Scientific (NYSE:BSX) jumped 4.4% in the morning session after the company reported strong third-quarter results that topped Wall Street's forecasts and raised its full-year financial outlook. 
Via StockStory · October 22, 2025
What's going on in today's session: S&P500 moverschartmill.com
Curious about the top performers within the S&P500 index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Via Chartmill · October 22, 2025
Boston Scientific Gains Momentum As Growth Broadens, Goldman Sachs Saysbenzinga.com
Goldman Sachs analyst David Roman reiterated a Buy rating and $120 price target for Boston Scientific after strong Q3 results and raised guidance.
Via Benzinga · October 22, 2025
Boston Scientific Soars: Q3 2025 Earnings Beat Ignites Medical Device Market
Boston Scientific (NYSE: BSX) has delivered an exceptional third-quarter 2025 earnings report, significantly surpassing analyst expectations and reinforcing its position as a leading innovator in the medical device industry. The strong performance, highlighted by robust sales growth and an upward revision of full-year guidance, has sent a positive signal to
Via MarketMinute · October 22, 2025
Boston Scientific Jumps On Strong Guidance, Heart Devices Fuel Topline Growthbenzinga.com
Boston Scientific Q3 revenue hit $5.07 billion, beating forecasts. The company raised its full-year guidance based on strong segment growth.
Via Benzinga · October 22, 2025
Boston Scientific Jumps On Third-Quarter Beat, Strong Guideinvestors.com
Boston Scientific stock jumped early Wednesday on a strong 2025 outlook following its third-quarter sales and earnings beat.
Via Investor's Business Daily · October 22, 2025
Beware The Death Cross: 3 Stocks Triggering This Spooky Signalmarketbeat.com
The Death Cross is something you never want to see on a stock you own. Take caution with these three companies that recently were visited by this scary signal.
Via MarketBeat · October 22, 2025
Boston Scientific’s (NYSE:BSX) Q3 Sales Top Estimates
Medical device company Boston Scientific (NYSE:BSX) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 20.3% year on year to $5.07 billion. Guidance for next quarter’s revenue was better than expected at $5.27 billion at the midpoint, 1.7% above analysts’ estimates. Its non-GAAP profit of $0.75 per share was 5.1% above analysts’ consensus estimates.
Via StockStory · October 22, 2025
Boston Scientific Corp (NYSE:BSX) Reports Strong Q3 2025 Earnings, Beats Estimateschartmill.com
Boston Scientific beats Q3 2025 earnings and revenue forecasts, reporting strong sales growth and issuing optimistic Q4 guidance.
Via Chartmill · October 22, 2025
What to Expect from Boston Scientific's Earningsbenzinga.com
Via Benzinga · October 21, 2025
Boston Scientific (BSX) Reports Q3: Everything You Need To Know Ahead Of Earnings
Medical device company Boston Scientific (NYSE:BSX) will be announcing earnings results this Wednesday morning. Here’s what to expect.
Via StockStory · October 20, 2025
21 Analysts Have This To Say About Boston Scientificbenzinga.com
Via Benzinga · October 17, 2025
Boston Scientific's Options: A Look at What the Big Money is Thinkingbenzinga.com
Via Benzinga · October 17, 2025
Earnings Scheduled For October 22, 2025benzinga.com
Via Benzinga · October 22, 2025
Boston Scientific To Acquire Nalu Medical In $600 Million Pain Relief Dealbenzinga.com
Boston Scientific Corp (NYSE: BSX) to acquire Nalu Medical Inc. for $600 million in cash. Deal expected to close in first half of 2026.
Via Benzinga · October 17, 2025
$1000 Invested In Boston Scientific 5 Years Ago Would Be Worth This Much Todaybenzinga.com
Via Benzinga · October 15, 2025
1 Profitable Stock with Promising Prospects and 2 We Find Risky
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Via StockStory · October 14, 2025
2 S&P 500 Stocks to Target This Week and 1 Facing Challenges
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.
Via StockStory · October 8, 2025
10 Health Care Stocks Whale Activity In Today's Sessionbenzinga.com
Via Benzinga · October 6, 2025
1 Cash-Producing Stock for Long-Term Investors and 2 That Underwhelm
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Via StockStory · October 6, 2025
Healthcare Sector Shines Amidst Market Turbulence, Bolstering S&P 500 Resilience
On October 2, 2025, the Healthcare sector emerged as a beacon of stability and growth within the S&P 500, delivering a robust positive performance that significantly contributed to the broader market's resilience. Despite prevailing anxieties, including a looming U.S. government shutdown and a disappointing jobs report, healthcare equities
Via MarketMinute · October 2, 2025
In today's session, there are S&P500 stocks with remarkable trading volume.chartmill.com
In today's session, there are S&P500 stocks with remarkable trading volume. Explore the stocks exhibiting unusual volume in Wednesday's session.
Via Chartmill · October 1, 2025